Business & Tech

Shire will pay $350 million to settle kickback charges

A sign sits in front of Shire's manufacturing facility in Lexington, Massachusetts in this file photo from July 18, 2014. U.S. pharmaceutical company AbbVie said October 14, 2014 it was reconsidering its $55 billion takeover of Shire in the wake of U.S. government moves to curb deals designed to cut tax, wiping $13 billion off the London-listed firm's stock price. REUTERS/Brian Snyder/Files (UNITED STATES - Tags: BUSINESS)

Shire PLC is based in Ireland, but the drug maker’s headquarters is in Lexington.

Drug maker Shire PLC has settled a case involving kickback allegations by the US Department of Justice and 37 states, according to New York attorney general Eric Schneiderman.

Under the settlement deal, Shire, which is based in Ireland but has its US headquarters in Lexington, agreed to pay the federal government $350 million, including $14.5 million that will go to state Medicaid programs. Wednesday’s deal finalizes an August settlement agreed to by the parties involved.

Advertisement

The agreement settles allegations that Shire and Advanced BioHealing Inc., a company it bought in 2011, employed kickbacks and other unlawful methods to improperly promote a bioengineered human skin substitute called Dermagraft.

In an e-mailed statement, Shire said it didn’t admit any wrongoing by agreeing to the payment.

“We are pleased to have reached a resolution on this matter and believe that the terms of the resolution reflect Shire’s extraordinary cooperation with the Department of Justice throughout its lengthy investigation,” a spokeswoman said.

Robert Weisman can be reached at robert.weisman@globe.com. Follow him on Twitter @GlobeRobW.
Loading comments...
Real journalists. Real journalism. Subscribe to The Boston Globe today.
You're reading  1 of 5 free articles.
Get UNLIMITED access for only 99¢ per week Subscribe Now >
You're reading1 of 5 free articles.Keep scrolling to see more articles recomended for you Subscribe now
We hope you've enjoyed your 5 free articles.
Continue reading by subscribing to Globe.com for just 99¢.
 Already a member? Log in Home
Subscriber Log In

We hope you've enjoyed your 5 free articles'

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week
Marketing image of BostonGlobe.com
Marketing image of BostonGlobe.com
Already a subscriber?
Your city. Your stories. Your Globe.
Yours FREE for two weeks.
Enjoy free unlimited access to Globe.com for the next two weeks.
Limited time only - No credit card required!
BostonGlobe.com complimentary digital access has been provided to you, without a subscription, for free starting today and ending in 14 days. After the free trial period, your free BostonGlobe.com digital access will stop immediately unless you sign up for BostonGlobe.com digital subscription. Current print and digital subscribers are not eligible for the free trial.
Thanks & Welcome to Globe.com
You now have unlimited access for the next two weeks.
BostonGlobe.com complimentary digital access has been provided to you, without a subscription, for free starting today and ending in 14 days. After the free trial period, your free BostonGlobe.com digital access will stop immediately unless you sign up for BostonGlobe.com digital subscription. Current print and digital subscribers are not eligible for the free trial.